International Myeloma Working Group guidelines for serum-free light chain analysis in multiple myeloma and related disorders
Angela Dispenzieri(Mayo Clinic), Bart Barlogie(University of Arkansas for Medical Sciences), Pieter Sonneveld(Erasmus MC Cancer Institute), Morie A. Gertz(Medical University of South Carolina), Hermann Einsele(Universitätsklinikum Würzburg), Mario Boccadoro(University of Turin), Jesús F. San Miguel(Clinica Universidad de Navarra), Robert A. Kyle(Mayo Clinic), Sagar Lonial(Emory University), Patrizia Tosi(Azienda Unità Sanitaria Locale Della Romagna), Michel Attal(Université Fédérale de Toulouse Midi-Pyrénées), Brian G.M. Durie(Cedars-Sinai Medical Center), Sundar Jagannath(Mount Sinai Hospital), Heinz Ludwig(Wilhelminen Hospital), María‐Victoria Mateos(Hospital Clínico San Carlos), W. Chen(Beijing Chaoyang Emergency Medical Center), Ingemar Turesson(Spanish Head & Neck Cancer Cooperative Group), Joan Bladé(Hospital Clínic de Barcelona), Kenneth C. Anderson(Dana-Farber Cancer Institute), Meletios Α. Dimopoulos(Korea University), Raymond L. Comenzo(Tufts Medical Center), Paul G. Richardson(Harvard University), Orhan Sezer(Charité - Universitätsmedizin Berlin), Antonio Palumbo(University Hospital Brno), S. Vincent Rajkumar(WinnMed), Kazuyuki Shimizu(Higashi Osaka City General Hospital), Michèle Cavo(Unknown), Giampaolo Merlini(University of Pavia), Roman Hájek(University Hospital Ostrava), Gareth J. Morgan(Hywel Dda University Health Board), D. Joshua(Royal Prince Alfred Hospital), Jean‐Luc Harousseau(Hospital de Santa Maria), R Powles(Parkside Hospital)
Cited by 808
Related Papers
The Global Syndemic of Obesity, Undernutrition, and Climate Change: The Lancet Commission report
|The Lancet|2019|3k
International Staging System for Multiple Myeloma
|Journal of Clinical Oncology|2005|2.9k
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
A Phase 2 Study of Bortezomib in Relapsed, Refractory Myeloma
|New England Journal of Medicine|2003|2.6k